Skip to main content
. 2018 Oct 9;19(10):3091. doi: 10.3390/ijms19103091

Figure 1.

Figure 1

DNA methylation and demethylation. DNMT3A is commonly mutated in acute myeloid leukemia (AML), IDH1, 2 mutations are found in AML, and TET2 is frequently mutated in all myeloid malignancies. Azacitidine and decitabine are DNA demethylating agents, inhibiting DNA methyl transferases (DNMTs).